GDG.D. PharmaceuticalsLIMITED · NEPAL नेपाली

Home / Investors

Preparing for the Nepal Stock Exchange

G.D. Pharmaceuticals is preparing for a proposed public offering and listing on NEPSE.

IPO roadmap

The path to listing

The detailed timeline will be finalised with the appointed Issue Manager.

  1. STEP 01Corporate restructuring
  2. STEP 02Financial strengthening
  3. STEP 03Regulatory approvals
  4. STEP 04Appointment of Issue Manager
  5. STEP 05Due diligence
  6. STEP 06Prospectus approval
  7. STEP 07IPO issuance
  8. STEP 08Listing on NEPSE

See the plant

A look inside our manufacturing plant

A walk through the Parwanipur plant: production sections, quality control laboratory and packaging lines.

Growth plan

Where we are heading

  • Expand manufacturing capacity
  • Launch new pharmaceutical formulations
  • Increase product registrations
  • Increase automation across production
  • Enter new export markets
  • Expand hospital and institutional business
  • Strengthen research and development

Use of capital

How proceeds will be used

Manufacturing capacity expansionMachinery & automationWorking capitalProduct developmentExport market expansionQuality & regulatory complianceMarketing & distribution

This page is for general information only and does not constitute an offer or solicitation to buy securities. Any public offering will be made solely through a prospectus approved by the Securities Board of Nepal (SEBON). Investors should read the approved prospectus before making any decision.

Investor enquiries

Partner with a GMP-certified manufacturer in Nepal

Talk to our team